Clinical utility of functional imaging with 18F-FDOPA in Von Hippel-Lindau syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 4, 2012, Pages

  Weisbrod, Allison B ^a   Kitano, Mio ^a   Gesuwan, Krisana ^a   Millo, Corina ^b   Herscovitch, Peter ^b   Nilubol, Naris ^a   Linehan, W Marston ^a   Kebebew, Electron ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; CATECHOLAMINE; CHROMOGRANIN A; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER SURGERY; CATECHOLAMINE BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; FUNCTIONAL NEUROIMAGING; HEALTH CARE UTILIZATION; HUMAN; HYPERMETABOLISM; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR LOCALIZATION; TUMOR VOLUME; VON HIPPEL LINDAU DISEASE;

ADULT; CENTRAL NERVOUS SYSTEM NEOPLASMS; COHORT STUDIES; CONTRAST MEDIA; DIHYDROXYPHENYLALANINE; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; VON HIPPEL-LINDAU DISEASE;

EID: 84859528027     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2626     Document Type: Article

References (19)

1. Kim JJ, Rini BI, Hansel DE 2010 Von Hippel Lindau syndrome. Adv Exp Med Biol 685:228-249
2. Shehata BM, Stockwell CA, Castellano-Sanchez AA, Setzer S, Schmotzer CL, Robinson H 2008 Von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects. Adv Anat Pathol 15:165-171 (Pubitemid 351591499)
3. Butman JA, Linehan WM, Lonser RR 2008 Neurologic manifestations of Von Hippel-Lindau disease. JAMA 300:1334-1342
4. Zhou J, Li NY, Zhou XJ, Zhou HB, Wu B, Jiang SJ, Ma HH, Zhang RS 2010 Clinicopathologic study of Von-Hippel-Lindau syndrome-related and sporadic and hemangioblastomas of central nervous system. Zhonghua Bing Li Xue Za Zhi 39:145-150
5. Eisenhofer G, Lenders JW, Linehan WM, Walther MM, Goldstein DS, Keiser HR 1999 Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von-Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 340:1872-1879 (Pubitemid 29272667)
6. Aprill BS, Drake 3rd AJ, Lasseter DH, Shakir KM 1994 Silent adrenal nodules in von Hippel-Lindau disease suggest pheochromocytoma. Ann Intern Med 120:485-487 (Pubitemid 24075226)
7. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH 1985 Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 26:576-585 (Pubitemid 16033416)
8. Kim WT, Ham WS, Ju HJ, Lee JS, Lee JS, Choi YD 2009 Clinical characteristics of renal cell carcinoma in Korean patients with von Hippel-Lindau disease compared to sporadic bilateral or multifocal renal cell carcinoma. J Korean Med Sci 24:1145-1149
9. 18F-Fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications. J Nucl Med 49:573-586
10. Hoegerle S, Altehoefer C, Ghanem N, Koehler G, Waller CF, Scheruebl H, Moser E, Nitzsche E 2001 Whole-body 18F DOPA PET for detection of gastrointestinal carcinoid tumors. Radiology 220:373-380 (Pubitemid 32667172)
11. Becherer A, Szabó M, Karanikas G, Wunderbaldinger P, Angelberger P, Raderer M, Kurtaran A, Dudczak R, Kletter K 2004 Imaging of advanced neuroendocrine tumors with 18F-FDOPA PET. J Nucl Med 45:1161-1167 (Pubitemid 47611661)
12. Koopmans KP, Neels OC, Kema IP, Elsinga PH, Sluiter WJ, Vanghillewe K, Brouwers AH, Jager PL, de Vries EG 2008 Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography. J Clin Oncol 26:1489-1495
13. Kaji P, Carrasquillo JA, Linehan WM, Chen CC, Eisenhofer G, Pinto PA, Lai EW, Pacak K 2007 The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome. Eur J Endocrinol 156:483-487 (Pubitemid 46672650)
14. Montravers F, Grahek D, Kerrou K, Ruszniewski P, de Beco V, Aide N, Gutman F, Grangé JD, Lotz JP, Talbot JN 2006 Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors? J Nucl Med 47: 1455-1462 (Pubitemid 47544931)
15. Hoegerle S, Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, Reincke M, Moser E, Neumann HP 2002 Pheochromocytomas: detection with 18FDOPA whole body PET - initial results. Radiology 222:507-512
16. Havekes B, Lai EW, Corssmit EP, Romijn JA, Timmers HJ, Pacak K 2008 Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging. Q J Nucl Med Mol Imaging 52:419-429
17. Taïeb D, Tessonnier L, Sebag F, Niccoli-Sire P, Morange I, Colavolpe C, De Micco C, Barlier A, Palazzo FF, Henry JF, Mundler O 2008 The role of 18-F-FDOPA and 18F-FDG PET in the management of malignant and multifocal phaeochromocytomas. Clin Endocrinol (Oxf) 69:580-586
18. Pacak K, Eisenhofer G, Goldstein DS 2004 Functional imaging of endocrine tumors: role of positron emission tomography. Endocr Rev 25:568-580 (Pubitemid 39096071)
19. Fliedner SM, Lehnert H, Pacak K 2010 Metastatic paraganglioma. Semin Oncol 37:627-637